[Tokyo, Japan / London, UK] Sosei Co. Ltd. (M-4565, TSE) announced today new appointments, effective September 16, 2004 to strengthen its senior management and R&D capabilities.
Appointed as Representative Director, Executive Vice President and CFO, Administration (Previously Board Director, Executive Vice President and CFO)
Yuzo TARUMI, Ph.D.
Appointed as Representative Director and Executive Vice President, R&D and New Business Development (Previou sly Representative Director and Executive Vice President, R&D)
Appointed as Board Director (Previously Chairman of the Board)
Appointed as Executive Auditor (Previously Auditor)
Appointed as Senior Vice President of Clinical Development (Previously Executive Auditor)
Yoshiyuki YAMAKAWA was appointed new Representative Director, Executive Vice President and CFO to strengthen our senior management post IPO. Yuzo TARUMI assumes additional responsibilities for New Business Development aimed for business expansion in the US. Kenzo NAKAJIMA focuses on Stem Cell Sciences KK where he serves as President & CEO. Toshiyuki KITAURA is appointed to strengthen Clinical Development utilising his professional background and Hiroyoshi USUDA succeeds as executive auditor following the resignation of KITAURA from that position.